Big Health’s Acquisition of Limbix

Lowenstein Sandler represented Big Health in the transaction. Big Health, the leading provider of non-drug digital treatments for mental health, announced the acquisition of Limbix, creators...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Tonix Pharmaceuticals’ $25 Million Acquisition of FDA-Approved Products from Upsher-Smith Laboratories

Lowenstein represented Tonix Pharmaceuticals Holding Corp. in the transaction. Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a clinical-stage biopharmaceutical company, announced its $25 million acquisition of two...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Floor’s Acquisition of WGMI.io

Lowenstein represented Floor in the transaction. Floor, a token-gated non-fungible token (NFT) portfolio tracking platform founded by executives from Robinhood, Venmo, and Button, announced the acquisition...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Aryeo’s $3.5 Million Capital Fund Raise

Lowenstein represented 645 Ventures as lead investor in the transaction. Aryeo, an Austin, Texas-based software platform provider for real estate photographers and media companies, announced its $3.5 million capital...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here